Possible effects sometimes include dry mouth, nervousness, higher pressure, and faster heartbeat
Ozempic, Wegovy may cause serious eye condition, study warns Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to the eye disorder non-arteritic anterior ischemic optic neuropathy, with diabetics on the drug having a four times higher risk and those taking it for weight loss having a seven times higher risk
However, many doctors still hesitate to prescribe these medications, and insurance coverage remains inconsistent
Conclusion GLP-1 is more than just a weight-loss aid
High Purity Figure 2
By now, its clear that semaglutide supports weight loss by curbing appetite, helping patients eat less and make healthier food choices